PT
PANDA Therapeutics
Switzerland · Biotech
PANDA Therapeutics develops an antibody-based platform targeting protein aggregates involved in Alzheimer’s disease.
Product
PANDA Therapeutics is a Zurich-based biotechnology venture developing a therapy designed to target multiple harmful protein aggregates, including amyloid-beta and tau. Its initial focus is Alzheimer’s disease.
Founded by Hui Zhang, PANDA aims to develop its platform through partnerships with pharmaceutical and biotechnology companies. It is preparing its operations, manufacturing strategy and regulatory plans ahead of clinical development.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Venture Kick Stage III | CHF 100K | Venture Kick — Participant |